Early health economic modelling for a treatment candidate in hidradenitis suppurativa

Damon Willems*, Mata Charokopou, Silvia M. A. A. Evers, Mickael Hiligsmann

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1516-1524
Number of pages9
JournalJournal of Medical Economics
Volume23
Issue number12
Early online date6 Nov 2020
DOIs
Publication statusPublished - 1 Dec 2020

Keywords

  • Economic evaluation
  • cost-effectiveness
  • value assessment
  • hidradenitis suppurativa
  • acne inversa
  • ADALIMUMAB
  • MODERATE

Cite this